The S&P 500 has been a cornerstone of wealth-building for decades, delivering average returns of about 10% annually through ...

Investors may choose to buy an equal-weight fund as a way to reduce their exposure to the largest companies or boost their ...

The initial headline number showed that the often overlooked gauge, which measures prices paid to domestic producers, rose by 0.9% in July. That was the fastest pace in three years, and much higher ...

The initial headline number showed that the often overlooked gauge, which measures prices paid to domestic producers, rose by 0.9% in July. That was the fastest pace in three years, and much higher ...

Barclays research analyst Julian Mitchell on Thursday outlined a mixed outlook for the U.S. multi-industry sector, ...

Investing.com -- Wells Fargo has initiated coverage on ArcelorMittal SA with an “equal weight” rating and a price target of ...

Barclays analyst Julian Mitchell downgraded Fortive (FTV) to Equal Weight from Overweight with a price target of $54, down from $58. The company’s ...

The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...

Morgan Stanley added that ELS is positioned for steady growth, with steady mid-single digit gains from internal operations ...

XSD offers exposure to 40 U.S. semiconductor stocks with a modified equal-weight approach. Click here for more information on ...

Incyte Corporation (NASDAQ: INCY) is one of the top most undervalued biotech stocks to buy now. Wells Fargo upgraded Incyte ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.